Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys

Obesity Research

Volumn 4, Issue 6, 1996, Pages 569-575

  Ortmeyer, Heidi K ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

D chiroinositol; Hyperinsulinemia; Macaca mulatto

Indexed keywords

INOSITOL; INSULIN;

ANIMAL; ARTICLE; BLOOD; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; GLUCOSURIA; INSULIN RESISTANCE; MACACA; METABOLISM; OBESITY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; TIME;

ANIMALS; BLOOD GLUCOSE; FOOD, FORTIFIED; GLYCOSURIA; INOSITOL; INSULIN; INSULIN RESISTANCE; MACACA MULATTA; OBESITY; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 0030279889     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1996.tb00271.x     Document Type: Article

References (10)

1. Arendrup K, Gregersen G, Hawley J, Hawthorne JN. High-dose dietary myo-inositol does not alter the ischemia phenomenon in human diabetes. Acta Neurol Scand 1989;80:99-102.
2. Carrington AL, Calcutt NA, Ettlinger CB, Gustafsson T, Tomlinson DR. Effects of treatment with myo-inositol or its 1,2,6-triphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol 1993;237:257-263.
3. Clements RS, Reynertson R. Myoinositol metabolism in diabetes mellitus: effect of insulin treatment. Diabetes 1977;26:215-221.
4. Clements RSJ, DeJesus PVJ, Winegrad AI. Raised plasma-myoinositol levels in uraemia and experimental neuropathy. Lancet 1973;2:1137-1141.
5. Daughaday WH, Larner J. The renal excretion of inositol in normal and diabetic human beings. J Clin Invest 1954;33:326-332.
6. DeJesus PVJ, Clements RSJ, Winegrad AI. Hypermyoinositolemic polyneuropathy in rats: A possible mechanism for uremic polyneuropathy. J Neurol Sci 1974;21:237-249.
7. Futerman AH, Low MG, Ackermann KE, Sherman WR, Silman I. Identification of covalently bound inositol in the hydrophobic membrane-anchoring domain of torpedo acetylcholinesterase. Biochem Biophys Res Comm 1985;129:312-317.
8. Gousse A, Yoshida M, Weiss RM, Latifpour J. Beta adrenergic receptor alterations in diabetic rat prostrate: effects of insulin and dietary myoinositol. Prostate 1991;19:121-131.
9. Greene DA, Jesus PVD, Winegrad AI. Effects of insulin and dietary myoinositol on unpaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 1975;55:1326-1336.
10. Gregersen G, Bertelsen B, Harbo H, et al. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurol Scand 1983;67:164-172.